Menu
en
de
fr
en
de
fr
Contact
About us
Team
Expertise
Blockchain & Crypto Assets
Capital Markets
Competition & Trade
Compliance
Corporate / M&A
Employment & Pensions
Energy
Environment, Social, Governance (ESG)
Financial Services
Insurance
IP & TMT
Life Sciences
Litigation & Arbitration
Private Clients
Private Equity & Venture Capital
Real Estate & Environment
Restructuring & Insolvency
Tax
White Collar Crime
Insights
Deals & Cases
News
Legal Updates
Publications
Events
Sanctions Resource Center
Corporate Law Reform 2020
Swiss Financial Market Regulation
Careers
Contact
Publication
Loading
Compulsory licensing in a (post) covid-19 world
By Barbara Abegg,
Lara Dorigo
, Peter Ling: IAM Life Sciences: Key issues for senior life sciences executives 2021, June 2021, 59-63
Share
IP & TMT
To the top
